Clarithromycin For Suspension
Product Images NDC 50090-0994

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clarithromycin (NDC 50090-0994). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 3 (Clarithro Fig3)

A survival curve graph comparing the proportion surviving over approximately 700 days since randomization between Clarithromycin and Placebo groups. The x-axis represents days since randomization, and the y-axis shows the proportion surviving from 0 to 1. The graph includes a legend distinguishing the Clarithromycin and Placebo lines.*

FDA Label Image

Structural Formula (Clarithro01)

Chemical structure diagram of clarithromycin, showing its molecular bonds and functional groups. The diagram includes detailed ring structures and hydroxyl groups characteristic of clarithromycin's macrolide antibiotic class.*

FDA Label Image

Label Image (Lbl500900994)

Label for Clarithromycin oral suspension 250 mg per 5 mL by A-S Medication Solutions. The label includes the NDC number 50090-0994-0, product number 5829-0, and storage instructions to keep refrigerated at 68-77 degrees Fahrenheit. The package size is 50 mL when mixed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.